James Boylan

James Boylan

Director/Board Member at COMPASS THERAPEUTICS, INC.

Net worth: - $ as of 31/05/2026

59 year
Health Technology
Finance
Consumer Services

Profile

James P.
Boylan
is Chief Executive Officer & Director at Enavate Sciences since 2022.
He is Independent Director at Immunome, Inc. since 2023, Independent Director at Compass Therapeutics, Inc. since 2022, Director at Graviton Bioscience Corp.
since 2024, Director at Zenas BioPharma (USA) LLC, and Independent Director at Zenas BioPharma, Inc. since 2022.
Former roles include Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, Independent Director at CAMP4 Therapeutics Corp.
from 2022 to 2025, President & Head-Investment at SVB Securities Holdings LLC from 2009 to 2021, and President & Head-Investment Banking at Leerink Partners LLC from 2019 to 2021.
Education includes undergraduate studies at Lehigh University and an MBA from Columbia Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 0 ( -.--% ) - $ 31/05/2026
10/06/2026 0 ( -.--% ) - $ 31/05/2026
-.--%
12/03/2026 0 ( -.--% ) - $ 31/05/2026

James Boylan active positions

CompaniesPositionStart
COMPASS THERAPEUTICS, INC. Director/Board Member 01/11/2022
IMMUNOME, INC. Director/Board Member 02/10/2023
Chief Executive Officer 01/05/2022
Director/Board Member -
Director/Board Member 01/01/2024

Former positions of James Boylan

CompaniesPositionEnd
CAMP4 THERAPEUTICS CORPORATION Director/Board Member 09/09/2025
President 01/04/2021
President 01/04/2021
Corporate Officer/Principal 01/05/2009
See the detail of James Boylan's experience

Training of James Boylan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

91

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Health Technology

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!